Tuesday, January 31, 2017

Pharma Reviews: Indian pharma industry fears tougher US stance on IP

The Indian pharma industry fears a tougher US government stance on intellectual property rules after US President Donald Trump asserted that ...
Read more: Indian pharma industry fears tougher US stance on IP